RiverTree Advisors’s Cardinal Health CAH Stock Holding History

RiverTree Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,872	Closed	-$221K	–	39
2022 Q4	$221K	Buy	+2,872	New	+$218K	0.18%	29

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RiverTree Advisors's CAH Position: Q1 2023 in Review

RiverTree Advisors sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 2,872 shares — an estimated $221K sold.

RiverTree Advisors first reported a position in CAH in Q4 2022 and held it in 1 quarter. The position peaked at $221K in Q4 2022. 907 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

RiverTree Advisors reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
RiverTree Advisors sold 2,872 Cardinal Health shares in Q1 2023, an estimated $221K.
RiverTree Advisors first reported a position in Cardinal Health in Q4 2022 and held it in 1 quarter.
RiverTree Advisors's Cardinal Health position peaked at $221K in Q4 2022.
907 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on RiverTree Advisors's 13F filing for Q1 2023, filed 15 May 2023.